Rivastigmine tartrate is a tartrate salt formed from rivastigmine and (R,R)-tartaric acid. It functions as a reversible cholinesterase inhibitor and is used as an active pharmaceutical ingredient in drug manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 129101-54-8
Rivastigmine
pharmaceutical raw material
8-Epitacrolimus
pharmaceutical raw material
Methyl [(5S,10R,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-{[4-(pyridin-2-yl)phenyl]methyl}-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate (non-preferred name)
pharmaceutical raw material
Leuprolide (5-9)
pharmaceutical raw material
Benidipine hydrochloride
pharmaceutical raw material
(2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
GWHQHAUAXRMMOT-MBANBULQSA-N
CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O